Reata Pharmaceuticals

-$0.25 (-0.30%) As of 6:09 PM UTC today

Why Robinhood?

You can buy or sell RETA and other stocks, options, and ETFs commission-free!

About RETA

Reata Pharmaceuticals, Inc. Class A Common Stock, also called Reata Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products.

CEO
J. Warren Huff
Employees
273
Headquarters
Plano, Texas
Founded
2002

RETA Key Statistics

Market Cap
3.01B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
468.50K
High Today
$84.19
Low Today
$80.92
Open Price
$82.87
Volume
146.46K
52 Week High
$186.82
52 Week Low
$79.40

RETA Earnings

-$3.67
-$2.83
-$2.00
-$1.16
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$2.10 per share
Actual
-$1.16 per share
Replay Earnings Call

You May Also Like

WTI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure